美迪西(688202)
 
 
  日线
顶尖财经网欢迎您!
  K线
 
 最新动态
  投资评级

研究机构 评级日期 最新评级 上次评级
长江证券 2023-11-21 买入
兴业证券 2023-11-16 增持
  盈利预测
据美迪西三季报分析:

  盈利能力有所削弱,总资产收益能力急剧下降

  成长能力明显恶化,营业收入由增长转为下降

  偿债能力明显改善,偿还流动负债能力很强

  运营能力有所削弱,流动资产合理利用率明显下降

  现金流能力有所加强,可持续经营能力加倍增强

  财务数据
    截至第三季度实现净利润1.15亿元,每股收益0.93元。

    截至第三季度最新股东权益267068.30万元,未分配利润83197.04万元。

    截至第三季度最新总资产355089.50万元,负债88021.20万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入1,183,189,967.59872,326,588.54451,400,695.331,658,930,295.46
营业总成本1,065,803,867.08687,706,554.52334,831,846.271,303,491,239.9
营业利润119,659,284.83183,986,667.03114,904,303.79370,596,846.43
利润总额119,347,196.63183,826,016.58114,696,639.33368,106,285.07
净利润114,900,869.11166,132,438.94101,568,576.29338,236,270.93
其他综合收益381,612.47376,982.48-154,313.21-14,979.95
综合收益总额115,282,481.58166,509,421.42101,568,576.29338,221,290.98
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计2,217,016,933.671,302,712,4571,178,798,922.611,072,633,100.49
非流动资产合计1,333,878,030.271,294,500,368.011,289,451,007.141,256,947,842.27
资产总计3,550,894,963.942,597,212,825.012,468,249,929.752,329,580,942.76
流动负债合计766,003,735.35755,126,472.16663,846,495.5617,042,323.77
非流动负债合计114,208,233.18105,848,608.7599,548,826.54109,753,887.96
负债合计880,211,968.53860,975,080.91763,395,322.04726,796,211.73
归属于母公司股东权益合计2,670,682,995.411,736,237,744.11,704,854,607.711,602,784,731.03
股东权益合计2,670,682,995.411,736,237,744.11,704,854,607.711,602,784,731.03
负债和股东权益合计3,550,894,963.942,597,212,825.012,468,249,929.752,329,580,942.76
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计982,573,416.08622,828,116.85296,351,036.341,387,621,926.8
经营活动现金流出小计991,342,424.7657,375,488.15313,794,044.521,408,952,743.76
经营活动产生的现金流量净额-8,769,008.62-34,547,371.3-17,443,008.18-21,330,816.96
投资活动现金流入小计426,713,927.7346,168,984.5-342,435,075.45
投资活动现金流出小计1,241,850,264.5172,720,703.3788,738,615.16654,057,021.49
投资活动产生的现金流量净额-815,136,336.77-126,551,718.87-88,738,615.16-311,621,946.04
筹资活动现金流入小计1,420,755,063.15311,000,00079,896,083.33285,514,665.47
筹资活动现金流出小计262,685,025.51160,994,586.126,453,114.52176,576,308.93
筹资活动产生的现金流量净额1,158,070,037.64150,005,413.953,442,968.81108,938,356.54
汇率变动对现金及现金等价物的影响1,955,557.662,167,502.61-770,934.148,172,549.21
现金及现金等价物净增加额336,120,249.91-8,926,173.66-53,509,588.67-215,841,857.25
期末现金及现金等价物余额532,145,915.66187,099,492.09142,516,077.08196,025,665.75
  主营收入+营业利润
 
  净利润+每股收益
  股东权益+未分配利润
 
  总资产+负债
  投资要点

    截至第三季度实现净利润1.15亿元,每股收益0.93元。

    截至第三季度最新股东权益267068.30万元,未分配利润83197.04万元。

    截至第三季度最新总资产355089.50万元,负债88021.20万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入1,183,189,967.59872,326,588.54451,400,695.331,658,930,295.46
营业总成本1,065,803,867.08687,706,554.52334,831,846.271,303,491,239.9
营业利润119,659,284.83183,986,667.03114,904,303.79370,596,846.43
利润总额119,347,196.63183,826,016.58114,696,639.33368,106,285.07
净利润114,900,869.11166,132,438.94101,568,576.29338,236,270.93
其他综合收益381,612.47376,982.48-154,313.21-14,979.95
综合收益总额115,282,481.58166,509,421.42101,568,576.29338,221,290.98
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计2,217,016,933.671,302,712,4571,178,798,922.611,072,633,100.49
非流动资产合计1,333,878,030.271,294,500,368.011,289,451,007.141,256,947,842.27
资产总计3,550,894,963.942,597,212,825.012,468,249,929.752,329,580,942.76
流动负债合计766,003,735.35755,126,472.16663,846,495.5617,042,323.77
非流动负债合计114,208,233.18105,848,608.7599,548,826.54109,753,887.96
负债合计880,211,968.53860,975,080.91763,395,322.04726,796,211.73
归属于母公司股东权益合计2,670,682,995.411,736,237,744.11,704,854,607.711,602,784,731.03
股东权益合计2,670,682,995.411,736,237,744.11,704,854,607.711,602,784,731.03
负债和股东权益合计3,550,894,963.942,597,212,825.012,468,249,929.752,329,580,942.76
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计982,573,416.08622,828,116.85296,351,036.341,387,621,926.8
经营活动现金流出小计991,342,424.7657,375,488.15313,794,044.521,408,952,743.76
经营活动产生的现金流量净额-8,769,008.62-34,547,371.3-17,443,008.18-21,330,816.96
投资活动现金流入小计426,713,927.7346,168,984.5-342,435,075.45
投资活动现金流出小计1,241,850,264.5172,720,703.3788,738,615.16654,057,021.49
投资活动产生的现金流量净额-815,136,336.77-126,551,718.87-88,738,615.16-311,621,946.04
筹资活动现金流入小计1,420,755,063.15311,000,00079,896,083.33285,514,665.47
筹资活动现金流出小计262,685,025.51160,994,586.126,453,114.52176,576,308.93
筹资活动产生的现金流量净额1,158,070,037.64150,005,413.953,442,968.81108,938,356.54
汇率变动对现金及现金等价物的影响1,955,557.662,167,502.61-770,934.148,172,549.21
现金及现金等价物净增加额336,120,249.91-8,926,173.66-53,509,588.67-215,841,857.25
期末现金及现金等价物余额532,145,915.66187,099,492.09142,516,077.08196,025,665.75
  十大流通股东
十大流通股东 报告期:2023-09-30
股东名称 持股数量(万股) 占总股本比例(%) 上期持股变化(万股)
陈金章1905.6317.360.00
陈春来795.717.250.00
王国林639.165.820.00
林长青547.374.990.00
陈国兴487.524.440.00
CHEN CHUN-LIN401.873.660.00
MEDICILON INCORPORATED354.083.230.00
全国社保基金四零六组合195.261.780.00
中国银行股份有限公司-华宝中证医疗交易型开放式指数证券投资基金147.061.341.87
香港中央结算有限公司143.071.30143.07
  主力控盘
  公司简介
美迪西 所属地域: 上海市 涉及概念: 减肥药,创新药,CRO概念,沪股通,融资融券
主营业务: 爱滋病药物、抗癌药增敏剂、基因工程疫苗及生物医药中间体的研发,转让自有技术成果,并提供相关技术咨询、技术服务及自有技术的进出口,药用化合物、精细化学品(除危险化学品、监控化学品、烟花爆竹、民用爆炸物品、易制毒化学品)的研发、批发及进出口。【依法须经批准的项目,经相关部门批准后方可开展经营活动】。
上市日期: 2019-11-05 每股净资产: 19.85元 每股收益: 0.93元 净利润: 1.15亿元 净利润增长率: -58.68%
营业收入: 11.83亿元 每股现金流: -0.07元 每股公积金: 12.29元 每股未分配利润: 6.18元 总股本: 1.35亿 流通股: 1.10亿
以上信息为合作方、加盟公司及会员收集,本站不拥有版权,版权归原作者所有,所载文章、数据仅供参考,据此操作,风险自负。

中 华 顶 尖 财 经 -- 中 华 顶 尖 网 络 信 息 服 务 中 心